Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development

BACKGROUND: Although mRNA vaccines have been efficient for combating a variety of tumors, their effectiveness against glioma remains unclear. There is growing evidence that immunophenotyping can reflect the comprehensive immune status and microenvironment of the tumor, which correlates closely with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shuai, Ba, Yixu, Ji, Hang, Wang, Fang, Du, Jianyang, Hu, Shaoshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484904/
https://www.ncbi.nlm.nih.gov/pubmed/34603319
http://dx.doi.org/10.3389/fimmu.2021.738435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484904/
https://www.ncbi.nlm.nih.gov/pubmed/34603319
http://dx.doi.org/10.3389/fimmu.2021.738435

Ejemplares similares